Candel Therapeutics, Inc. (CADL)

Candel Therapeutics Market Cap

Candel Therapeutics has a market cap or net worth of $342.06 million as of May 17, 2024. Its market cap has increased by 588.26% in one year.

• Market Cap: 342.06M
• Enterprise Value: 337.17M
• 1-Year Change: 588.26%
• Ranking: #3267
• Category: Small-Cap
• Stock Price: $11.50

Market Cap Chart

Since the IPO on July 27, 2021, Candel Therapeutics's market cap has increased from $222.39M to $342.06M, an increase of 53.81%. That is a compound annual growth rate of 16.57%.

Market Cap History

Date	Market Cap	% Change
May 17, 2024	342.10M	-9.45%
May 16, 2024	377.80M	-9.27%
May 15, 2024	416.40M	30.82%
May 14, 2024	318.30M	6.35%
May 13, 2024	299.30M	9.43%
May 10, 2024	273.50M	-6.53%
May 9, 2024	292.60M	-7.93%
May 8, 2024	317.80M	12.94%
May 7, 2024	281.40M	8.36%
May 6, 2024	259.70M	-1.89%
May 3, 2024	264.70M	6.99%
May 2, 2024	247.40M	5.64%
May 1, 2024	234.20M	13.19%
Apr 30, 2024	206.90M	9.99%
Apr 29, 2024	188.10M	0.32%
Apr 26, 2024	187.50M	-0.64%
Apr 25, 2024	188.70M	6.25%
Apr 24, 2024	177.60M	2.42%
Apr 23, 2024	173.40M	6.64%
Apr 22, 2024	162.60M	7.19%
Apr 19, 2024	151.70M	-5.31%
Apr 18, 2024	160.20M	0.31%
Apr 17, 2024	159.70M	-7.63%
Apr 16, 2024	172.90M	1.23%
Apr 15, 2024	170.80M	-12.63%

View and export this data all the way back to 2021. Sign Up Today.

Related Stocks

Company	Market Cap
Precigen	353.39M
Pulmonx	348.37M
Jasper Therapeutics	347.42M
Zynex	345.71M
Solid Biosciences	343.50M
Skye Bioscience	339.62M
Nanobiotix	338.73M
Erasca	338.05M